Dr. Joann G. Elmore Research Group
The Elmore Research Group
About Our Research Group
The Elmore Research Group advances cancer screening and diagnosis of melanoma and breast cancer by combining clinical insights with artificial intelligence and machine learning techniques to uncover specific strategies to enhance efficiency and accuracy of cancer diagnosis and reduce physician variability. The research group portfolio spans cancer screening, medical technology, statistical methods, medical education, health IT (including big data), and OpenNotes, patient engagement, and healthcare delivery. The majority of our research studies occur at both University of California, Los Angeles and the University of Washington, along with a network of talented collaborators at leading institutions across the United States.
In the News
View All News
Summary aims to clarify guidance around dense breasts
Supplemental screening for breast cancer (breast MRI or ultrasonography) should be based on comprehensive risk assessment (not breast density alone).
Are there differences in ME/CFS rates between those who had COVID-19 vs those who did not have COVID-19?
The rates of people identified with ME/CFS-like illness were similar between people with and without COVID-19
Cancer screenings for women in their 40s
National Geographic reports on cancer screenings and quotes Dr. Joann G. Elmore
Task force updates guidance for breast cancer screenings for women 40 and older
CNN story highlights and quotes JAMA Editorial by Dr. Joann Elmore